Collaborations

Companies collaborate on DNA vaccine technology

Published in Vaccine Weekly, August 31st, 2005

CytoGenix, Inc., (CYGX) and Aldevron announced a collaboration to conduct experiments with a DNA vaccine produced using CytoGenix's proprietary DNA production process.

CytoGenix scientists will prepare the synthetic DNA vaccine designed to stimulate an immune response to a hepatitis B surface antigen. Aldevron will test the activity of this DNA vaccine in models established and validated by Aldevron scientists. Aldevron will conduct the experimental evaluation of the DNA vaccine with the company's proprietary Genetic Immunization and Antibody (GIA) technology.

Dr. Malcolm Skolnick, CytoGenix's president and CEO, commented, "This mutually beneficial...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2005-08-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry